微藻治疗性:从生物质到骨组织工程
Diana Pacheco1,2, Tatiana M F Patrício2,3, Abílio J F N Sobral1
1Coimbra Chemistry Centre-Institute of Molecular Sciences (CQC-IMS), Department of Chemistry, University of Coimbra, Coimbra, 3004-535, Portugal.
Materials today. Bio
|March 4, 2026
概括
微藻衍生的因其生物相容性和骨质生成活性,对骨组织工程有很大的希望. 本综述探讨了它们的提取,特性和在开发用于骨再生的先进生物材料中的应用.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 海洋生物技术 海洋生物技术
背景情况:
- 骨组织工程面临着缺乏细胞兼容性和生物活性的合成生物材料的挑战.
- 寻求自然和仿生替代品,以改善与本地骨组织的整合.
- 微藻提供生物活性化合物的可持续来源,包括具有治疗潜力的.
研究的目的:
- 为提供微藻衍生的骨再生提供全面的审查.
- 涵盖制造过程,生物特性和治疗应用.
- 检查临床翻译的挑战和先进的交付系统的潜力.
主要方法:
- 文献综述侧重于微藻蛋白质提取,净化和表征.
- 分析生物活动,特别是骨质生成潜力.
- 对治疗应用和临床研究状态的评估.
主要成果:
- 微藻衍生的具有很高的细胞兼容性和骨质生成活性.
- 它们的调节性质使它们适合开发先进的生物材料.
- 与先进的输送系统的集成可以实现针对患者的植入物.
结论:
- 微藻类是骨再生医学中治疗性的重要,可持续的资源.
- 这些具有下一代生物材料的潜力.
- 对临床翻译和传递系统的进一步研究是有必要的.
相关概念视频
01:40Bone Remodeling
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
01:31Bone Remodeling and Repair
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during bone...